Aytu Biopharma (AYTU) Capital Expenditures (2015 - 2025)
Aytu Biopharma (AYTU) posted quarterly Capital Expenditures of $17000.0 for Q4 2025, up 183.33% year-over-year from $6000.0 in Q4 2024, and little changed quarter-over-quarter from $17000.0 in Q2 2025.
Aytu Biopharma (AYTU) Capital Expenditures (2015 - 2025) Analysis & Trends
Aytu Biopharma (AYTU) has reported Capital Expenditures for 9 consecutive years, with $17000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Capital Expenditures rose 183.33% year-over-year to $17000.0; the TTM figure through Mar 2026 stood at $34000.0 (down 93.7% YoY), while the FY2025 annual figure was $228000.0, down 30.7% from the prior year.
- Capital Expenditures steadied at $17000.0 in Q4 2025 per AYTU's latest filing, from $17000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $329000.0 in Q2 2024 and bottomed at -$13.1 million in Q2 2021.
- Historically, Capital Expenditures has averaged -$1.8 million across 3 years, with a median of $17000.0 in 2025.
- Annual changes were most pronounced in 2021 — Capital Expenditures slumped 123.21% — and 2025, when it soared 183.33%.
- Aytu Biopharma's Capital Expenditures stood at -$13.1 million in 2021, then soared by 100.05% to $6000.0 in 2024, then jumped by 183.33% to $17000.0 in 2025.
- Business Quant data shows AYTU's Capital Expenditures at $17000.0 in Q4 2025, $17000.0 in Q2 2025, and $69000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Aytu Biopharma | 24.75 Mn | -1.96 Mn | 7.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17,000.00 |
| Dec 31, 2025 | 17,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Mar 31, 2025 | 69,000.00 |
| Mar 31, 2025 | 69,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Sep 30, 2024 | 136,000.00 |
| Sep 30, 2024 | 136,000.00 |
| Jun 30, 2024 | 329,000.00 |
| Jun 30, 2024 | 329,000.00 |
| Jun 30, 2021 | -13.06 Mn |
| Jun 30, 2021 | -13.06 Mn |
| Jun 30, 2020 | -5.85 Mn |
| Jun 30, 2020 | -5.85 Mn |
| Mar 31, 2020 | 1.35 Mn |
| Mar 31, 2020 | 1.35 Mn |
| Dec 31, 2019 | 4.50 Mn |
| Dec 31, 2019 | 4.50 Mn |